Filing
2nd Quarter - Report
Lobbying activity
3
Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations.
Issues related to PEPFAR.
ITrade issues related to generic medicines.